BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on oral solutions containing levetiracetam: Risk of overdosage due to medication errors

Active substance: levetiracetam

In several cases, oral administration of levetiracetam solutions (100 mg/ml) resulted in accidental (up to 10-fold) overdosage, especially in children aged 11 years and younger.

Download DHPC/Information letter , Download_VeroeffentlichtAm_EN PDF, 97KB, File is accessible